<DOC>
	<DOCNO>NCT01152385</DOCNO>
	<brief_summary>The purpose study compare effect glucose control 3 different AZD1656 dosing regimen placebo Japanese type 2 diabetes mellitus ( T2DM ) patient , evaluate change HbA1c baseline end treatment 4 month .</brief_summary>
	<brief_title>Japan Dose Regimen Study AZD1656 Japanese Type 2 Diabetes Mellitus Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>woman nonchildbearing potential . Provision inform consent prior study specific procedure Naïve T2DM patient HbA1c ≥ 7.5 % ≤ 10 % T2DM Patients treat one two oral antihyperglycaemic agent ( ) HbA1c ≥ 7.5 % ≤ 9.5 % enrolment visit ( Visit1 ) Clinically relevant medical history concurrent disease cardiovascular disease , renal disease , hepatic disease haematological disease . The investigator ( ) judge Subject participate study accord screen test medical history . Participation another clinical trial and/or intake another investigational drug within last 30 day prior enrolment visit</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Japanese</keyword>
	<keyword>phase 2</keyword>
	<keyword>AZD1656</keyword>
	<keyword>efficacy</keyword>
	<keyword>dose regimen</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>